Trevi Therapeutics Inc. (TRVI) at a glance

Trevi Therapeutics Inc. (TRVI) is a Healthcare company. It trades at $14.62. It does not pay a dividend. Vestovix scores it 53/100 overall. Its strongest dimension is Momentum (76/100) and its weakest is Income (40/100).

Price
$14.62
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$5.41 to $16.12
Vestovix Score53/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
76